CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹184 Cr | ₹142 Cr | ₹192 Cr | ₹344 Cr | ₹236 Cr |
What is the latest Total Current Liabilities ratio of CONCORD BIOTECH ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹184 Cr |
Mar2024 | ₹142 Cr |
Mar2023 | ₹192 Cr |
Mar2022 | ₹344 Cr |
Mar2021 | ₹236 Cr |
How is Total Current Liabilities of CONCORD BIOTECH Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹184 Cr | 29.48 | |
Mar2024 | ₹142 Cr | -25.90 | |
Mar2023 | ₹192 Cr | -44.27 | |
Mar2022 | ₹344 Cr | 45.91 | |
Mar2021 | ₹236 Cr | - |
Compare Total Current Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹15,776.8 Cr | -5.1% | -9% | -20.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | -0.3% | 3.2% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,458.0 Cr | 7.2% | 8.6% | 6.8% | Stock Analytics | |
CIPLA | ₹125,842.0 Cr | 3% | 0.7% | -2.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,547.0 Cr | -0.5% | NA | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,866.0 Cr | -1.1% | -5.3% | -6.3% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -5.1% |
-9% |
-20.1% |
SENSEX | 1% |
0.9% |
1.2% |
You may also like the below Video Courses